+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Global Forecast 2025-2030- Product Image
Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Global Forecast 2025-2030- Product Image
Sale

Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715781
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Ophthalmic Drug Delivery System Market grew from USD 16.35 billion in 2023 to USD 17.85 billion in 2024. It is expected to continue growing at a CAGR of 9.59%, reaching USD 31.04 billion by 2030.

The ophthalmic drug delivery system encompasses a range of technologies and methodologies crafted to deliver therapeutic agents specifically to the eye structure, thereby treating conditions like glaucoma, macular degeneration, and infections. The necessity for these systems arises from the complex anatomy of the eye, which poses significant challenges for drug absorption. The primary applications are seen in sustained release formulations, solutions, emulsions, and contact lenses embedded with medication. The systems see widespread use across hospitals, ophthalmic clinics, and research institutes, addressing both chronic and acute eye conditions.

Market growth is driven by the rising prevalence of eye disorders associated with aging populations and lifestyle changes, alongside increasing investments in R&D for advanced delivery systems. The integration of nanotechnology and biopharmaceuticals presents potential opportunities, enabling enhanced bioavailability and targeted delivery, which appeals to key stakeholders. The surge in minimally invasive surgical techniques also complements the demand for innovative drug delivery mechanisms. However, limitations stem from regulatory hurdles and the high cost of novel development initiatives, which can deter fast-paced advancements. Additionally, challenges persist in tailoring solutions that overcome the eye's natural defense mechanisms without inducing adverse reactions.

The best areas for innovation lie in developing biodegradable implants and micro-needle systems that provide controlled drug release over an extended period. Enhancing patient compliance through user-friendly delivery formats and tapping into digital health technologies, such as smart contact lenses with tracking sensors, also offers lucrative opportunities. The dynamic nature of the market calls for continuous monitoring of emerging biotech platforms and strategic collaborations with academic institutions to stay ahead. Nonetheless, sustaining growth requires addressing pricing pressures, ensuring rigorous clinical evaluations, and navigating intellectual property intricacies. By embracing these approaches, businesses can unlock new avenues for success in this evolving field.

Understanding Market Dynamics in the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising number of eye disorders in geriatric population
    • Increasing preference for early diagnosis and prevention
    • Growing government initiatives for eye care
  • Market Restraints
    • Associated complications of ophthalmic drug delivery systems
  • Market Opportunities
    • Ongoing advancements in ophthalmic drug delivery system
    • Favorable reimbursement policies
  • Market Challenges
    • Concern regarding poor bioavailability and instability for dissolved drugs

Exploring Porter’s Five Forces for the Ophthalmic Drug Delivery System Market

Porter’s Five Forces framework further strengthens the insights of the Ophthalmic Drug Delivery System Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Ophthalmic Drug Delivery System Market

External macro-environmental factors deeply influence the performance of the Ophthalmic Drug Delivery System Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include AptarGroup, Inc., Bausch Health Companies Inc., Biocorp, Envisia Therapeutics, EyePoint Pharmaceuticals, Inc., Gerresheimer AG, Mati Therapeutics, Inc., Merck & Co., Novartis AG, Ocular Therapeutix Inc., Oculis Pharma, Owen Mumford, Pfizer Inc., Terumo Corporation, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Technology
    • Contact Lenses
    • Episcleral Implants
    • Eye Drops
    • Hydrogels
    • Injectable Particulate Systems
    • Intravitreal Implants
    • Iontophoresis
    • Micro-Electromechanical
    • Microneedles
    • Nano Careers
    • Nano Microparticles
    • Punctal Plugs
  • Production Technology
    • 3D Printing
    • Compression Molding
    • Electrospinning
    • Extrusion
    • Formulation
    • Micro Patterning
  • Material
    • Collagen
    • Fatty acids
    • Hydrogels
    • Liposomes
    • PDO/PVA
    • PLA-PEG
    • PLGA
    • Polycaprolactone
    • Polyorthoesters
    • TMC
  • Delivery Route
    • Intracameral
    • Intraocular
    • Intravitreal
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of eye disorders in geriatric population
5.1.1.2. Increasing preference for early diagnosis and prevention
5.1.1.3. Growing government initiatives for eye care
5.1.2. Restraints
5.1.2.1. Associated complications of ophthalmic drug delivery systems
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in ophthalmic drug delivery system
5.1.3.2. Favorable reimbursement policies
5.1.4. Challenges
5.1.4.1. Concern regarding poor bioavailability and instability for dissolved drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Ophthalmic Drug Delivery System Market, by Technology
6.1. Introduction
6.2. Contact Lenses
6.3. Episcleral Implants
6.4. Eye Drops
6.5. Hydrogels
6.6. Injectable Particulate Systems
6.7. Intravitreal Implants
6.8. Iontophoresis
6.9. Micro-Electromechanical
6.10. Microneedles
6.11. Nano Careers
6.12. Nano Microparticles
6.13. Punctal Plugs
7. Ophthalmic Drug Delivery System Market, by Production Technology
7.1. Introduction
7.2. 3D Printing
7.3. Compression Molding
7.4. Electrospinning
7.5. Extrusion
7.6. Formulation
7.7. Micro Patterning
8. Ophthalmic Drug Delivery System Market, by Material
8.1. Introduction
8.2. Collagen
8.3. Fatty acids
8.4. Hydrogels
8.5. Liposomes
8.6. PDO/PVA
8.7. PLA-PEG
8.8. PLGA
8.9. Polycaprolactone
8.10. Polyorthoesters
8.11. TMC
9. Ophthalmic Drug Delivery System Market, by Delivery Route
9.1. Introduction
9.2. Intracameral
9.3. Intraocular
9.4. Intravitreal
10. Americas Ophthalmic Drug Delivery System Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Ophthalmic Drug Delivery System Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Ophthalmic Drug Delivery System Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET DYNAMICS
TABLE 7. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EPISCLERAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EYE DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INJECTABLE PARTICULATE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO-ELECTROMECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO CAREERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY NANO MICROPARTICLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PUNCTAL PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY ELECTROSPINNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRO PATTERNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PDO/PVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLA-PEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYORTHOESTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TMC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRACAMERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAOCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 55. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 58. CANADA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 59. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 62. MEXICO OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 77. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. CHINA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 81. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 84. INDIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 92. JAPAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 116. THAILAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 129. DENMARK OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 130. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 133. EGYPT OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 134. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. FINLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 142. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 145. GERMANY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 146. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 150. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 153. ITALY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 162. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. NORWAY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 166. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 169. POLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 170. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 172. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. QATAR OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 186. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 189. SPAIN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 190. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 193. SWEDEN OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 198. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 199. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 201. TURKEY OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
TABLE 210. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 211. OPHTHALMIC DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Ophthalmic Drug Delivery System Market, which are profiled in this report, include:
  • AptarGroup, Inc.
  • Bausch Health Companies Inc.
  • Biocorp
  • Envisia Therapeutics
  • EyePoint Pharmaceuticals, Inc.
  • Gerresheimer AG
  • Mati Therapeutics, Inc.
  • Merck & Co.
  • Novartis AG
  • Ocular Therapeutix Inc.
  • Oculis Pharma
  • Owen Mumford
  • Pfizer Inc.
  • Terumo Corporation
  • Teva Pharmaceuticals

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 17.85 Billion
Forecasted Market Value ( USD ) by 2030 $ 31.04 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Ophthalmic Drug Delivery Systems Market Size, Share & Trends Analysis Report By Technology (Eye Drops, Contact Lenses), By Delivery Route, By Production Technology, By Material, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 190 Pages
  • Global
From
Advanced Drug Delivery Systems Markets and Technologies - Product Image

Advanced Drug Delivery Systems Markets and Technologies

  • Report
  • 265 Pages
  • Global
From
Hydrogel-based Drug Delivery System Market by Delivery Route, Polymer Origin - Global Forecast 2025-2030 - Product Image

Hydrogel-based Drug Delivery System Market by Delivery Route, Polymer Origin - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Global Forecast 2025-2030 - Product Image

Novel Drug Delivery Systems Market by Route of Administration, Mode, End-User - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 - 2030 - Product Image

Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From

About the Ophthalmic Drug Delivery System Market

The Ophthalmic Drug Delivery System market is a subset of the larger Drug Delivery market, which focuses on the development and delivery of drugs to the eye. Ophthalmic drug delivery systems are designed to provide targeted delivery of drugs to the eye, with the goal of improving patient outcomes. These systems can be used to deliver a variety of drugs, including antibiotics, anti-inflammatory agents, and anti-glaucoma medications. Ophthalmic drug delivery systems can be divided into two main categories: topical and systemic. Topical delivery systems involve the application of drugs directly to the eye, while systemic delivery systems involve the administration of drugs through the bloodstream. Both types of systems have advantages and disadvantages, and the choice of system depends on the type of drug being delivered and the desired outcome. The Ophthalmic Drug Delivery System market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Alcon, Allergan, Bausch + Lomb, Santen, and Shire. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.